Jul 09, 2021 09:00 AM IST
In a two-stage approach, the phase 3 clinical study will initially investigate the efficacy of the COVID-19 vaccine formulation targeting the original novel coronavirus strain.
- Jul 07, 2021 09:12 AM IST
Sanofi is looking to conduct a part of its 35,000-participant global Phase 3 trial of its COVID-19 vaccine in India.
- May 17, 2021 12:35 PM IST
The vaccine hit a major setback in December, when its developers announced that it did not appear to work well in older adults and that they would have to delay plans to test it in a Phase 3 trial, the crucial test that will assess the vaccine’s effectiveness.
- May 12, 2021 10:32 PM IST
GCPL’s stock soared the most since it went public following the announcement of the new Managing Director and CEO, Sudhir Sitapati – an HUL veteran.
- Apr 17, 2021 07:00 PM IST
Kaizad Hazari has more than 28 years of experience and has previously worked with HDFC Ltd, GSK, Hindalco Industries, Raymonds, Asian Paints and ICICI Bank. Prior to Dr Reddy’s, Dasgupta, an alumnus of the NLSIU Bangalore 1994 LLM batch, has had stints at Schneider Electric, International Paper , Honeywell International, General Electric and the United Nations High Commission for Refugees.
- Feb 22, 2021 05:41 PM IST
The move comes after the drugmakers in December said their vaccine would be delayed after clinical trials showed an insufficient immune response in older people.
- Feb 03, 2021 01:35 PM IST
In a joint statement on Wednesday, the partners said they were targeting a possible launch in 2022.
- Oct 28, 2020 12:35 PM IST
COVAX aims to deliver 2 billion vaccine doses around the world by the end of 2021, and more than 180 nations have joined the plan.
- Oct 21, 2020 10:31 AM IST
RSV vaccine development has been fraught with setbacks for decades but the pharma industry is gearing up to bring a first inoculation to market over the next few years.
- Sep 03, 2020 11:02 AM IST
Sanofi and GSK said in a joint statement on Thursday they had started the "Phase 1/2" trial for their adjuvanted COVID-19 vaccine, which they hope to make available across the world.
- Jul 29, 2020 11:30 AM IST
Financial terms of the agreement were not disclosed. Sanofi and GSK, which had first teamed up in April, confirmed in a statement that regulatory approval for their vaccine could be achieved by the first half of 2021 if clinical data was to be positive.
- Jul 20, 2020 12:10 PM IST
CureVac's existing COVID-19 mRNA and rabies vaccines research programmes are not included in the deal, the companies said.
- Jul 05, 2020 02:02 PM IST
Britain is considering an option to buy the vaccine if human trials, which are due to begin in September, are successful.
- Jun 20, 2020 12:21 PM IST
According to the British group's chief medical officer for vaccines Thomas Breuer, who says the company prefers the slow and steady approach of focusing on an established technology that has the best chance of reaching the widest possible demographic.
- Jun 11, 2020 05:03 PM IST
GSK is betting on its adjuvant technology to support companies developing COVID-19 vaccines.
- May 28, 2020 02:44 PM IST
The London-listed company said it was in talks with governments on backing for the programme, which would effectively allow for a scaling up of production of future successful vaccines
- May 07, 2020 02:35 PM IST
The funds will help GSK in its goal of reinvigorating its drug development pipeline, having made costly bets on experimental cancer treatments and future cell and gene therapies amid sluggish revenue growth.
- May 06, 2020 04:41 PM IST
The price band for the block deals has been set between Rs 1,850 to Rs 1,950 a share
- Apr 15, 2020 10:22 AM IST
As per the partnership, France-based Sanofi will contribute its S-protein COVID-19 antigen, which is based on recombinant DNA technology.
- Jan 07, 2020 02:35 PM IST
GSK's nutrition business is largely led by the Horlicks brand.
- Nov 13, 2019 03:51 PM IST
Bharat Biotech acquired Chiron Behring from GSK in March this year and commercial operations at the company's Ankleshwar (Gujarat) unit restarted in May.
- Sep 03, 2019 07:16 PM IST
The National Pharmaceutical Pricing Authority has asked manufacturers and distributors to immediately supply stocks in areas where a shortage has been reported.
- Jul 24, 2019 05:30 PM IST
Incoming chairman Symonds is currently deputy group chairman at banking group HSBC, where he has also been an independent non-executive director since April 2014.
- Feb 15, 2019 06:42 PM IST
The acquisition allows Hyderabad-headquartered Bharat Biotech to become world's largest manufacturer of rabies vaccines.
- Jan 21, 2019 01:17 PM IST
Before joining GSK, Hampton was chairman of Royal Bank of Scotland Group Plc and J Sainsbury plc .